Biotech firm Immunic Inc (NASDAQ:IMUX) is set to disclose its Q3 2023 financial results and provide a corporate update on November 14, 2023, before the U.S. financial markets open. A webcast is scheduled for 8:00 am ET. The company specializes in developing orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases.
Advertisement Go to Proactive UK Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Advertisement Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Advertisement Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com